Bluejay Diagnostics (BJDX) Non-Current Assets (2020 - 2026)
Bluejay Diagnostics (BJDX) reported Non-Current Assets of $1.6 million for Q1 2026, down 4.38% on a YoY basis from $1.7 million in Q1 2025, and down 1.48% sequentially from $1.7 million in Q4 2025.
Bluejay Diagnostics (BJDX) Non-Current Assets (2020 - 2026) Analysis & Trends
Bluejay Diagnostics (BJDX) has 7 years of Non-Current Assets data on file, last reported at $1.6 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets fell 4.38% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $6.5 million (down 8.63% YoY), and the FY2025 full-year result was $1.7 million, down 5.85% from the prior year.
- Non-Current Assets fell to $1.6 million in Q1 2026, from $1.7 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $2.0 million in Q1 2023 to a low of $760675.0 in Q1 2022.
- A 5-year average of $1.6 million and a median of $1.7 million in 2025 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets surged 393.1% in 2022 and fell 18.18% in 2024, its largest moves.
- Tracing BJDX's Non-Current Assets over 5 years: stood at $1.7 million in 2022, then dropped by 4.91% to $1.6 million in 2023, then climbed by 6.73% to $1.8 million in 2024, then slipped by 5.85% to $1.7 million in 2025, then dropped by 1.48% to $1.6 million in 2026.
- Business Quant data shows BJDX's Non-Current Assets at $1.6 million in Q1 2026, $1.7 million in Q4 2025, and $1.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | Bluejay Diagnostics | 2,754.24 | 2,754.24 | - | 1.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.63 Mn |
| Dec 31, 2025 | 1.66 Mn |
| Sep 30, 2025 | 1.54 Mn |
| Jun 30, 2025 | 1.65 Mn |
| Mar 31, 2025 | 1.71 Mn |
| Dec 31, 2024 | 1.76 Mn |
| Sep 30, 2024 | 1.79 Mn |
| Jun 30, 2024 | 1.84 Mn |
| Mar 31, 2024 | 1.63 Mn |
| Dec 31, 2023 | 1.65 Mn |
| Sep 30, 2023 | 1.72 Mn |
| Jun 30, 2023 | 1.90 Mn |
| Mar 31, 2023 | 1.99 Mn |
| Dec 31, 2022 | 1.73 Mn |
| Sep 30, 2022 | 1.77 Mn |
| Jun 30, 2022 | 1.02 Mn |
| Mar 31, 2022 | 760,675.00 |
| Dec 31, 2021 | 358,385.00 |
| Sep 30, 2021 | 358,845.00 |
| Dec 31, 2020 | 459,138.00 |